Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

No single biomarker is reliable enough for diagnosing and assessing SLE.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

B cells can both help and hinder the body's defense against melanoma.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

A patient with lupus experienced a condition where their immune cells became overactive.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

MK-5108 is safe and shows potential against tumors, especially alone.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Melatonin and photobiomodulation are effective for treating Alopecia X in German Spitz dogs.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Pulsed electric field treatment may help shrink untreated liver tumors.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Dupilumab can both heal and cause hair loss.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.